Biocytogen (HKEX: 02315) is a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies. Founded on gene editing technology, Biocytogen leverages genetically engineered proprietary RenMice® (RenMab/RenLite®/RenNano®/RenTCR-mimic) platforms for fully human monoclonal/bispecific/multispecific antibody discovery, bispecific antibody-drug conjugate discovery, nanobody discovery and TCR-mimic antibody discovery, and has established a sub-brand, RenBiologics, to explore global partnerships for an off-the-shelf library of >400,000 fully human antibody sequences against approximately 1000 targets. As of June 30, 2023, 50 therapeutic antibody and multiple clinical asset co-development/out-licensing/transfer agreements and 42 target-nominated RenMice® licensing projects have been established around the globe, including several partnerships with multinational pharmaceutical companies (MNCs). Biocytogen pioneered the generation of drug target knock-in humanized models for preclinical research, and currently provides a few thousand off-the-shelf animal and cell models under the company’s sub-brand, BioMice, along with preclinical pharmacology and gene-editing services for clients worldwide. Headquartered in Beijing, Biocytogen has branches in China (Haimen Jiangsu, Shanghai), USA (Boston, San Francisco), and Germany (Heidelberg).
BioDot
BioDot has provided low-volume dispensing solutions to the Diagnostics, Drug Discovery, and Life Sciences fields since 1994. Our systems deliver accurate microliter-to-picoliter dispensing, enabling laboratories to integrate automation and miniaturization into workflows while maintaining sample integrity and experimental reproducibility. Visit our booth to see our new dynamic platform in operation and explore its applications in modern laboratory workflows.
BioDuro
BioDuro, an Advent International portfolio company is a trusted, leading contract research development, and manufacturing organization (CRDMO) for 30 years. We provide our biotech and pharmaceutical partners with fully integrated services to support their efforts from target identification through to commercial drug product manufacturing. The company is based in the US with operations in China, totaling 2,000+ scientists and 7 global sites across 6 cities. Core expertise includes small and large molecule discovery, development and scale-up, support for IND submission, and unique technology platforms such as bioavailability enhancement of insoluble compounds. The one-stop-shop operation helps biotech and pharma partners across the globe to significantly accelerate discovery and de-risk development to create higher value outcomes. We adhere to one global highest standard of compliance and business operation code. Science-driven, customer-oriented, flexible, people-focused culture enables us to provide top-tier integrated, fast and flexible tailored services to our customers to meet their unique needs and accelerate our development timeline. For more information about BioDuro, please visit our website at www.bioduro-sundia.com | BioDuro, an Advent portfolio company, is a CRDMO with a 30-year proven track record. Headquartered in Irvine, California, BioDuro employs more than 2,000 scientists with deep expertise in small- and large-molecule discovery, development, and manufacturing. We provide fully integrated drug discovery services spanning chemistry, biology, and pharmacokinetics (DMPK), along with comprehensive IND-enabling capabilities, including both drug substance and drug product development.
Biocodex
Since 1953, Biocodex teams have been passionately committed to a single mission: providing innovative healthcare solutions to women, men and children worldwide. With over 1,600 employees, Biocodex is committed to serving millions of people around the world. Biocodex USA markets Florastor® daily probiotic, (Saccharomyces boulardii CNCM I-745®) that supports digestive balance and strengthens the immune system. Florastor is the only probiotic in North America to contain the original and exclusive yeast strain, S. boulardii CNCM I-745, supported by over 70 years of research, over 1,000 publications, more than 130 clinical studies and over 13 meta-analyses. Unlike most bacteria-based probiotics, Florastor is naturally resistant to antibiotics and therefore can be taken at the same time to enhance patient compliance.
Bettersize Inc
Bettersize provides instruments to analyze particle size, shape, charge, and density as well as powder characteristics such as bulk density. With over 22,000 devices in use and more than 106 patents, Bettersize is Asia’s leader in the field. Our devices utilize a variety of methods to analyze particles such as laser diffraction, dynamic light scattering, and static and dynamic image analysis. For really small particles we use dynamic light scattering. To analyze bigger particles, we utilize laser diffraction, static, and dynamic image analysis. One of our most popular devices, the Bettersizer S3 Plus incorporates both laser diffraction and dynamic image analysis simultaneously. Bettersize offers two static image analyzers, the manually operated BeVision S1, and the automated BeVision M1. If you are looking for even more automation and have a need to measure flowing powders, we offer the BeVision D2. Bettersize measures particle Charge using Phase Analysis Light Scattering (PALS) which works well with biological materials dispersed in high salt liquids as well as conventional particle suspensions. Bettersize’s BetterPyc 380-FS uses gas pycnometry to measure particle density, volume, open cell content and solid content of suspensions. We look forward to speaking with you at the Analytica USA in Ohio. Our team of regional sales managers is available to meet with you and discuss your needs at your convenience. We can be reached at (833) 699-SIZE (7493) at our offices in Costa Mesa CA. Hope to see you soon! | Bettersize Instruments is a leading manufacturer of analytical instrumentation. Our independent R&D and in-house production facilities ensure exceptional product quality. Our product line includes laser particle size analyzer, particle shape, zeta potential, and powder characteristics. We provides solutions for your quality control to your advanced research applications. | Bettersize provides advanced instruments for precise analysis of particle size, shape, zeta potential, powder characteristics, and physical stability. Our comprehensive product range helps scientists and engineers better understand material properties and optimize research and production. Our technologies include laser diffraction, dynamic light scattering, image analysis, and gas pycnometry. With strict quality control and exceptional customer service, Bettersize is trusted by over 22,000 businesses worldwide.
Best Cure Foundation with Best Medical International
Best Medical International (BMI), a TeamBest Global company, encompasses a family of trusted organizations and companies that specialize in providing innovative, high-quality, and efficient solutions for brachytherapy, vascular brachytherapy, and external beam radiation therapy. BMI manufactures and supplies Iodine-125 and Palladium-103 seeds, needles, templates, applicators, catheters, fiducial markers, dosimeter systems, the NovosteTM Beta-CathTM System, and a variety of other products for brachytherapy and other radiation therapy applications. Additionally, BMI and other TeamBest companies manufacture a wide range of products such as cyclotrons for medical isotopes production, GammaBeam teletherapy systems, blood irradiators, particle therapy accelerators, AccuBoost system, QA/QC instruments and ultrasound imaging systems. Our goal is to become the go-to partner for clinicians who seek all their radiation therapy and oncology product and service requirements.
BeOne Medicines
BeOne Medicines is a global oncology company discovering and developing innovative treatments that are more accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. The Company has a growing global team of nearly 12,000 colleagues spanning six continents who are driven by scientific excellence and exceptional speed to reach more patients than ever before. To learn more, please visit https://beonemedicines.us/ and follow us on LinkedIn, X, Facebook and Instagram.
BD
BD is a medical technology company advancing health by improving discovery, diagnostics and delivery. Our portfolio, leadership and partnerships make a difference for global healthcare. | BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD helps customers enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. | BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD helps customers enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. please visit bd.com. | BD Pyxis™ MedBank™ medication and supply management solutions help increase inventory visibility and address your medication storage and security challenges to ensure medications and supplies are available when and where they are needed. BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD helps customers enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. bd.com | BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD helps customers enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. bd.com
Bayer
Bayer is committed to delivering SCIENCE FOR A BETTER LIFE by advancing a portfolio of innovative treatments. The oncology franchise includes both marketed products and clinical development compounds, which reflect the company’s approach to research: prioritizing targets and pathways with the potential to impact the way that cancer is treated. | Bayer is a global life sciences leader in healthcare and nutrition. Building on a 150-year legacy in healthcare. Bayer is committed to improving patient lives by developing therapies and delivering first-in-class educational and support programs to meet their needs | Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to benefit people by supporting efforts to overcome the major challenges presented by a growing aging population. Bayer is committed to the principles of sustaining development, and the Bayer brand stands for trust, reliability, and quality throughout the world. See Bayer’s Privacy Statement at https://www.bayer.com/en/privacy-statement. | Bayer is a global life sciences leader in healthcare & nutrition. Building on a 150-yr legacy in healthcare, Bayer is committed to improving patient lives by developing therapies & delivering 1st-in-class educational & support programs to meet needs. | Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to benefit people by supporting efforts to overcome the major challenges presented by a growing aging population. Bayer is committed to the principles of sustaining development, and the Bayer brand stands for trust, reliability, and quality throughout the world. Bayer Medical Information: https://askmed.bayer.comPrivacy Statement: https://labeling.bayerhealthcare.com/html/privacy.htm | Building on a century of expertise, Bayer Radiology is committed to advancing radiology, guided daily by our purpose—everyone deserves clear answers about their health. With a passionate team and a presence in more than 140 countries, Bayer is a global leader in medical imaging. Our mission is to shape the patient experience, beginning with diagnostic care, to help improve patient outcomes. Bayer Radiology’s leading radiology portfolio features contrast agents and devices for precise administration across modalities including computed tomography (CT), X-ray and magnetic resonance (MR), and positron emission tomography (PET). The portfolio is complemented by an end-to-end diagnostic support ecosystem that includes power injection systems with sterile disposables, 24/7 equipment service, enterprise informatics, and clinical support. Fully committed to the ongoing advancement of medical imaging, Bayer Radiology continues to pioneer solutions that will help health care teams answer critical questions about the diagnosis and monitoring of serious diseases—because everyone deserves clear answers about their health.
Azenta Life Sciences
GENEWIZ from Azenta Life Sciences is a global leader in genomic services. GENEWIZ empowers research by providing high-quality, precision-based solutions from research use only to pre-clinical/clinical, enabling scientists to make breakthroughs faster and more efficiently. Key services include Next Generation and Sanger sequencing, gene synthesis, gene-to-discovery solutions including antibody production, viral packaging and mRNA synthesis. For more information visit www.Genewiz.com. Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling life science organizations around the world to bring impactful breakthroughs and therapies to market faster. Azenta is headquartered in Burlington, MA, with operations in North America, Europe and Asia. For more information visit www.Azenta.com.